0001209191-23-041087.txt : 20230705 0001209191-23-041087.hdr.sgml : 20230705 20230705163016 ACCESSION NUMBER: 0001209191-23-041087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOYER ANDREW S CENTRAL INDEX KEY: 0001239546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 231069586 MAIL ADDRESS: STREET 1: C/O WATSON PHARMA INC STREET 2: 360 MOUNT KEMBLE AVE CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-30 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001239546 BOYER ANDREW S C/O AMNEAL PHARMACEUTICALS, INC. BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President 0 Class A Common Stock 2023-06-30 4 M 0 23095 A 285612 D Class A Common Stock 2023-06-30 4 F 0 11571 3.10 D 274041 D Restricted Stock Units 2023-06-30 4 M 0 23095 0.00 D Class A Common Stock 23095 0 D Represents the gross number of shares of Class A Common Stock, par value $0.01 per share (the "Class A Common Stock") issuable to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares of Class A Common Stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. On August 1, 2020, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021. /s/ Chris Daly, Attorney-in-Fact 2023-07-05